Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

L Cindolo1, G Benvenuto, P Salvatore

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Centro di Endocrinologia ed Oncologia Sperimentale G. Salvatore del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Naples, Italy.

International Journal of Cancer
|February 13, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of COVID-19 on sexual behavior, male sexual function, and reproductive health: an interdisciplinary narrative review from a urological perspective.

International urology and nephrology·2026
Same author

Management of NOACs in patients undergoing water vapour thermal therapy (REZUM) for benign prostatic obstruction: a comprehensive review.

World journal of urology·2025
Same author

Beyond decentralized compliance: a call for a central regulatory office for AI in healthcare.

Virchows Archiv : an international journal of pathology·2025
Same author

Injection density in Rezūm®: Less might not be more. A multicentric international study.

Actas urologicas espanolas·2025
Same author

Empathy at school project: Effects of didactics of emotions® on emotional competence, cortisol secretion and inflammatory profile in primary school children. A controlled longitudinal psychobiological study.

Comprehensive psychoneuroendocrinology·2023
Same author

Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2022

This study found increased levels of galectin-1 in high-grade bladder tumors, suggesting its potential role in cancer progression. Galectin-3 also showed elevated expression across various tumor grades.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Galectins (galectin-1 and galectin-3) are galactoside-binding proteins implicated in tumor progression.
  • These proteins represent potential therapeutic targets for cancer treatment.

Purpose of the Study:

  • To investigate the expression patterns of galectin-1 and galectin-3 in human bladder transitional-cell carcinomas.
  • To correlate galectin expression with tumor histological grade and clinical stage.

Main Methods:

  • Analysis of 38 human bladder transitional-cell carcinomas and 5 normal urothelium samples.
  • Quantification of galectin-1 and galectin-3 mRNA levels.
  • Western blot and immunohistochemical analysis to assess protein content.

Related Experiment Videos

Main Results:

  • Galectin-1 mRNA levels were significantly elevated in high-grade tumors compared to normal bladder tissue and low-grade tumors.
  • Western blot and immunohistochemistry confirmed higher galectin-1 protein content in tumors.
  • Galectin-3 mRNA levels were increased in most tumors but showed no significant difference across histological grades.

Conclusions:

  • Galectin-1 expression is upregulated in high-grade bladder tumors, indicating a potential role in advanced bladder cancer.
  • Galectin-3 is also upregulated in bladder tumors, but its expression is less dependent on histological grade.
  • Both galectins warrant further investigation as potential biomarkers and therapeutic targets in bladder cancer.